Molecular Human Reproduction, Vol. 6, No. 6, 498-503,
June 2000
© 2000 European Society of Human Reproduction and Embryology
Ovary and oogenesis |
TGFß receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes
Reproductive Medical Center, Division of Obstetrics and Gynecology, Department of Women and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden
Abstract
We have recently found that values of the transforming growth factor (TGF)ß1 in human ovarian follicular fluid obtained during ovarian stimulation for IVF were higher in women who subsequently became pregnant following embryo transfer. We therefore postulated that TGFß1 may have a beneficial effect on the preimplantation embryo and improve the chances of a successful implantation. We have used reverse transcriptionpolymerase chain reaction (RTPCR) and immunohistochemistry to investigate the presence in human oocytes and preimplantation embryos of the essential components of the TGFß signalling pathway, TGFß receptors type I and II and the substrate proteins Smad 2 and 3. We found that both receptors, as well as Smad 2 and 3, were present in the unfertilized oocyte, whereas only the type I receptor and Smad 2 and 3 were present at the blastocyst stage. At the 4-cell and 8-cell stages neither of the receptors was present, but Smad 2 and 3 were present at both stages. These findings support our hypothesis that the TGFß1 in follicular fluid may interact with the oocyte and preimplantation embryo via TGFß receptors, and that TGFß signalling may be important for the development of the oocyte and the preimplantation embryo.
IVF/oocyte/signal transduction/Smad/TGFß
Notes
1 To whom correspondence should be addressed at: Division of Obstetrics and Gynecology, Reproductive Medical Center, Department of Woman and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden. E-mail: gabriel.fried{at}fyfa.ki.se
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. L Jones, C. Stoikos, J. K Findlay, and L. A Salamonsen TGF-{beta} superfamily expression and actions in the endometrium and placenta. Reproduction, August 1, 2006; 132(2): 217 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. V. Ingman, R. L. Robker, K. Woittiez, and S. A. Robertson Null Mutation in Transforming Growth Factor {beta}1 Disrupts Ovarian Function and Causes Oocyte Incompetence and Early Embryo Arrest Endocrinology, February 1, 2006; 147(2): 835 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.Z. Li, X. Sun, A. Stavreus-Evers, and K. Gemzell-Danielsson Effect of mifepristone on the expression of cytokines in the human Fallopian tube Mol. Hum. Reprod., July 1, 2004; 10(7): 489 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gueripel, M. Benahmed, and A. Gougeon Sequential Gonadotropin Treatment of Immature Mice Leads to Amplification of Transforming Growth Factor {beta} Action, Via Upregulation of Receptor-Type 1, Smad 2 and 4, and Downregulation of Smad 6 Biol Reprod, March 1, 2004; 70(3): 640 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and W. Ge Spatial Expression Patterns of Activin and Its Signaling System in the Zebrafish Ovarian Follicle: Evidence for Paracrine Action of Activin on the Oocytes Biol Reprod, December 1, 2003; 69(6): 1998 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pangas, A. W. Rademaker, D. A. Fishman, and T. K. Woodruff Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2644 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, J. Oakley, and E. A. McGee Stage-Specific Expression of Smad2 and Smad3 During Folliculogenesis Biol Reprod, June 1, 2002; 66(6): 1571 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Drummond, M. T. Le, J.-F. Ethier, M. Dyson, and J. K. Findlay Expression and Localization of Activin Receptors, Smads, and {beta}glycan to the Postnatal Rat Ovary Endocrinology, April 1, 2002; 143(4): 1423 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tomic, S.G. Brodie, C. Deng, R.J. Hickey, J.K. Babus, L.H. Malkas, and J.A. Flaws Smad 3 May Regulate Follicular Growth in the Mouse Ovary Biol Reprod, April 1, 2002; 66(4): 917 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F.C. Chow, K.-F. Lee, S. T.H. Chan, and W. S.B. Yeung Quantification of transforming growth factor {beta}1 (TGF{beta}1) mRNA expression in mouse preimplantation embryos and determination of TGF{beta} receptor (type I and type II) expression in mouse embryos and reproductive tract Mol. Hum. Reprod., November 1, 2001; 7(11): 1047 - 1056. [Abstract] [Full Text] [PDF] |
||||




